Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the P2X7 receptor: a comparative analysis of conventional methods and AlphaFold.

Frontiers in pharmacology·2026
Same author

Modulation of Patient-Derived Tumor Organoids by SARS-CoV-2 Variants Across Cancer Types: A Study Combining Morphology, Inflammation, and Whole-Exome Profiling.

International journal of molecular sciences·2026
Same author

Light, Dyes, and Action: Photodynamic Inactivation of <i>Leishmania amazonensis</i> Using Methylene Blue, New Methylene Blue, and Novel Ruthenium-Based Derivatives.

Biology·2025
Same author

Preparing for Practice: A Comparative Analysis of Anesthesiology Residency Competencies in Brazil, Spain, and the United Kingdom.

Journal of medical education and curricular development·2025
Same author

Joannesia princeps Vell. inhibits purinergic P2Y receptors and presents antinociceptive and anti-inflammatory effects.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Anesthesiology competencies in undergraduate medical education: a comparative study of curriculum frameworks in Brazil, Spain, and the United Kingdom.

BMC medical education·2025

Related Experiment Video

Updated: Oct 4, 2025

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.1K

Graph Neural Networks as a Potential Tool in Improving Virtual Screening Programs.

Luiz Anastacio Alves1, Natiele Carla da Silva Ferreira1, Victor Maricato1

  • 1Laboratory of Cellular Communication, Oswaldo Cruz Institute - Fiocruz, Rio de Janeiro, Brazil.

Frontiers in Chemistry
|February 7, 2022
PubMed
Summary
This summary is machine-generated.

Graph neural networks (GNNs) offer a promising approach to enhance virtual screening (VS) for drug discovery. This deep learning method could significantly improve the identification of potential drug candidates from natural products, overcoming limitations of current VS techniques.

Keywords:
GNNdeep learningdrug discoverynatural productsvirtual screening

More Related Videos

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.7K
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.1K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.7K
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.3K

Area of Science:

  • Computational chemistry and cheminformatics
  • Artificial intelligence in drug discovery
  • Pharmacology and medicinal chemistry

Background:

  • Traditional drug discovery yields a low success rate, with less than 1% of researched drugs reaching the market.
  • Virtual screening (VS) offers cost and time efficiencies but has not significantly improved the number of approved drugs.
  • Current VS methods rely on physics and quantum mechanics, with limited success in identifying viable drug candidates.

Purpose of the Study:

  • To explore the potential of graph neural networks (GNNs) as a tool to enhance virtual screening.
  • To evaluate the application of GNNs for natural product drug discovery.
  • To discuss the advantages, disadvantages, and future prospects of GNNs in drug discovery.

Main Methods:

  • Review of existing literature on virtual screening methodologies.
  • Analysis of graph neural network (GNN) applications in computational chemistry.
  • Discussion of GNN integration with traditional VS algorithms and standalone use.

Main Results:

  • Graph neural networks (GNNs) show potential to improve the accuracy and efficiency of virtual screening.
  • GNNs can be applied to natural product libraries, expanding the scope of drug discovery.
  • Current limitations include challenges with spatial coordinates and the need for adequate datasets.

Conclusions:

  • GNNs represent a powerful deep learning approach that could revolutionize drug discovery.
  • Overcoming current obstacles is crucial for realizing the full potential of GNNs in identifying novel therapeutics.
  • The integration of GNNs may significantly increase the success rate of bringing new drugs to market.